GLP-1s, Fasting, and the Future of Women’s Metabolic Health

GLP-1s, Fasting, and the Future of Women’s Metabolic Health

May 27, 2026 · 1h 8m · Season 7 · Episode 341

About this episode

Dr. Mindy Pelz discusses the impact of GLP-1 medications on women's metabolic health and the benefits of fasting.

GLP-1 medications are changing the conversation around weight loss, metabolism, and women’s health. But are we asking the right questions about long-term health? In this solo episode, Dr. Mindy Pelz breaks down the science behind GLP-1 drugs like Ozempic, Wegovy, and Mounjaro, including what they do well, where concerns are emerging, and how fasting mimics many of the same metabolic benefits naturally. Dr. Mindy explores: • The connection between GLP-1 drugs and muscle loss • Why women over 40 need to think differently about metabolism • New research linking GLP-1s to declining bone density • How fasting impacts glucagon, ketones, and fat burning • The importance of protein, refeeding, and resistance training • Why metabolic flexibility matters more than rapid weight loss • Natural ways to stimulate your body’s own GLP-1 production This episode is not about fear or shame. It’s about helping you understand your options so you can make informed decisions for your body, your hormones, and your long-term health. For more resources related to today’s episode, visit the podcast episode page: https://www.drmindypelz.com/ep341 Connect with Dr. Mindy: Join Reset Academy Watch the episodes…

People in this episode

Host: Dr. Mindy Pelz

Topics covered

Keywords

Mentioned in this episode

Products: Ozempic, Wegovy, Mounjaro

More episodes of The Resetter Podcast with Dr. Mindy

Explore listener stats, chart rankings, contacts and more on the The Resetter Podcast with Dr. Mindy podcast page.